HK Stock MarketDetailed Quotes

09688 ZAI LAB

Watchlist
  • 20.550
  • -0.400-1.91%
Market Closed Dec 13 16:08 CST
22.32BMarket Cap-10.61P/E (TTM)

ZAI LAB Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Turnover
44.32%289.92M
42.53%187.65M
38.78%87.15M
24.03%266.72M
31.78%200.89M
38.74%131.66M
34.40%62.8M
49.01%215.04M
52.22%152.44M
66.38%94.9M
Operating income
44.32%289.92M
42.53%187.65M
38.78%87.15M
24.03%266.72M
31.78%200.89M
38.74%131.66M
34.40%62.8M
49.01%215.04M
52.22%152.44M
66.38%94.9M
Cost of sales
-49.25%-105.34M
-52.48%-68.77M
-57.56%-33.62M
-29.45%-95.82M
-32.93%-70.58M
-36.46%-45.1M
-36.40%-21.34M
-41.69%-74.02M
-73.88%-53.09M
-79.89%-33.05M
Other costs
---433K
---85K
----
----
----
----
----
----
----
----
Operating expenses
-49.86%-105.77M
-52.67%-68.85M
-57.56%-33.62M
-29.45%-95.82M
-32.93%-70.58M
-36.46%-45.1M
-36.40%-21.34M
-41.69%-74.02M
-73.88%-53.09M
-79.89%-33.05M
Gross profit
41.32%184.15M
37.25%118.8M
29.11%53.53M
21.19%170.9M
31.17%130.31M
39.96%86.56M
33.39%41.46M
53.16%141.02M
42.72%99.35M
59.96%61.85M
Selling expenses
-8.61%-216.12M
-14.16%-148.9M
-10.69%-69.19M
-8.74%-281.61M
-6.44%-198.98M
-8.34%-130.43M
-9.68%-62.51M
-18.34%-258.97M
-25.25%-186.95M
-33.40%-120.39M
Research and development expenses
0.91%-182.25M
7.10%-116.27M
-12.74%-54.65M
7.17%-265.87M
16.20%-183.92M
-4.35%-125.15M
9.99%-48.47M
50.04%-286.41M
45.30%-219.46M
65.34%-119.94M
Special items of operating profit
----
----
----
--10M
--10M
--10M
----
----
----
----
Operating profit
11.69%-214.23M
7.95%-146.37M
-1.13%-70.31M
9.34%-366.57M
21.00%-242.59M
10.90%-159.02M
12.84%-69.52M
42.24%-404.36M
36.14%-307.06M
55.12%-178.48M
Financing income
-5.00%28.02M
-6.56%18.99M
-5.61%9.66M
172.92%39.8M
463.38%29.49M
1,390.90%20.32M
5,342.55%10.23M
565.84%14.58M
347.05%5.24M
197.60%1.36M
Financing cost
---1.35M
---605K
---113K
----
----
----
----
----
----
----
Special items of earning before tax
146.53%12.14M
81.63%-5.76M
-28.12%7.29M
85.28%-7.84M
67.17%-26.09M
27.10%-31.34M
490.68%10.15M
-861.91%-53.29M
-540.81%-79.47M
-3,746.14%-42.99M
Earning before tax
26.66%-175.42M
21.34%-133.75M
-8.80%-53.47M
24.48%-334.62M
37.27%-239.19M
22.75%-170.04M
40.19%-49.14M
37.01%-443.07M
22.52%-381.3M
44.42%-220.11M
After-tax profit from continuing operations
26.66%-175.42M
21.34%-133.75M
-8.80%-53.47M
24.48%-334.62M
37.27%-239.19M
22.75%-170.04M
40.19%-49.14M
37.01%-443.07M
22.52%-381.3M
44.42%-220.11M
Special items of earning after tax
----
----
----
----
----
----
----
79.09%-221K
59.67%-221K
-6.25%-221K
Earning after tax
26.66%-175.42M
21.34%-133.75M
-8.80%-53.47M
24.51%-334.62M
37.31%-239.19M
22.82%-170.04M
40.35%-49.14M
37.08%-443.29M
22.56%-381.52M
44.39%-220.33M
Profit attributable to shareholders
26.66%-175.42M
21.34%-133.75M
-8.80%-53.47M
24.51%-334.62M
37.31%-239.19M
22.82%-170.04M
40.35%-49.14M
37.08%-443.29M
22.56%-381.52M
44.39%-220.33M
Basic earnings per share
28.00%-0.18
22.22%-0.14
0.00%-0.05
23.91%-0.35
37.50%-0.25
21.74%-0.18
44.44%-0.05
93.93%-0.46
24.53%-0.4
47.73%-0.23
Diluted earnings per share
28.00%-0.18
22.22%-0.14
0.00%-0.05
23.91%-0.35
37.50%-0.25
21.74%-0.18
44.44%-0.05
93.93%-0.46
24.53%-0.4
47.73%-0.23
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
UAS
UAS
UAS
UAS
UAS
UAS
UAS
UAS
UAS
UAS
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Turnover 44.32%289.92M42.53%187.65M38.78%87.15M24.03%266.72M31.78%200.89M38.74%131.66M34.40%62.8M49.01%215.04M52.22%152.44M66.38%94.9M
Operating income 44.32%289.92M42.53%187.65M38.78%87.15M24.03%266.72M31.78%200.89M38.74%131.66M34.40%62.8M49.01%215.04M52.22%152.44M66.38%94.9M
Cost of sales -49.25%-105.34M-52.48%-68.77M-57.56%-33.62M-29.45%-95.82M-32.93%-70.58M-36.46%-45.1M-36.40%-21.34M-41.69%-74.02M-73.88%-53.09M-79.89%-33.05M
Other costs ---433K---85K--------------------------------
Operating expenses -49.86%-105.77M-52.67%-68.85M-57.56%-33.62M-29.45%-95.82M-32.93%-70.58M-36.46%-45.1M-36.40%-21.34M-41.69%-74.02M-73.88%-53.09M-79.89%-33.05M
Gross profit 41.32%184.15M37.25%118.8M29.11%53.53M21.19%170.9M31.17%130.31M39.96%86.56M33.39%41.46M53.16%141.02M42.72%99.35M59.96%61.85M
Selling expenses -8.61%-216.12M-14.16%-148.9M-10.69%-69.19M-8.74%-281.61M-6.44%-198.98M-8.34%-130.43M-9.68%-62.51M-18.34%-258.97M-25.25%-186.95M-33.40%-120.39M
Research and development expenses 0.91%-182.25M7.10%-116.27M-12.74%-54.65M7.17%-265.87M16.20%-183.92M-4.35%-125.15M9.99%-48.47M50.04%-286.41M45.30%-219.46M65.34%-119.94M
Special items of operating profit --------------10M--10M--10M----------------
Operating profit 11.69%-214.23M7.95%-146.37M-1.13%-70.31M9.34%-366.57M21.00%-242.59M10.90%-159.02M12.84%-69.52M42.24%-404.36M36.14%-307.06M55.12%-178.48M
Financing income -5.00%28.02M-6.56%18.99M-5.61%9.66M172.92%39.8M463.38%29.49M1,390.90%20.32M5,342.55%10.23M565.84%14.58M347.05%5.24M197.60%1.36M
Financing cost ---1.35M---605K---113K----------------------------
Special items of earning before tax 146.53%12.14M81.63%-5.76M-28.12%7.29M85.28%-7.84M67.17%-26.09M27.10%-31.34M490.68%10.15M-861.91%-53.29M-540.81%-79.47M-3,746.14%-42.99M
Earning before tax 26.66%-175.42M21.34%-133.75M-8.80%-53.47M24.48%-334.62M37.27%-239.19M22.75%-170.04M40.19%-49.14M37.01%-443.07M22.52%-381.3M44.42%-220.11M
After-tax profit from continuing operations 26.66%-175.42M21.34%-133.75M-8.80%-53.47M24.48%-334.62M37.27%-239.19M22.75%-170.04M40.19%-49.14M37.01%-443.07M22.52%-381.3M44.42%-220.11M
Special items of earning after tax ----------------------------79.09%-221K59.67%-221K-6.25%-221K
Earning after tax 26.66%-175.42M21.34%-133.75M-8.80%-53.47M24.51%-334.62M37.31%-239.19M22.82%-170.04M40.35%-49.14M37.08%-443.29M22.56%-381.52M44.39%-220.33M
Profit attributable to shareholders 26.66%-175.42M21.34%-133.75M-8.80%-53.47M24.51%-334.62M37.31%-239.19M22.82%-170.04M40.35%-49.14M37.08%-443.29M22.56%-381.52M44.39%-220.33M
Basic earnings per share 28.00%-0.1822.22%-0.140.00%-0.0523.91%-0.3537.50%-0.2521.74%-0.1844.44%-0.0593.93%-0.4624.53%-0.447.73%-0.23
Diluted earnings per share 28.00%-0.1822.22%-0.140.00%-0.0523.91%-0.3537.50%-0.2521.74%-0.1844.44%-0.0593.93%-0.4624.53%-0.447.73%-0.23
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards UASUASUASUASUASUASUASUASUASUAS
Audit Opinions ------Unqualified Opinion------Unqualified Opinion----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
HK
Overall
Symbol
Price
% Chg

No Data

Investment Theme Biotechnology
Biotechnology
Intraday-1.65%
HKEX Secondary Listings
HKEX Secondary Listings
Intraday-2.50%